SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-14-001478
Filing Date
2014-04-23
Accepted
2014-04-22 17:31:15
Documents
6
Period of Report
2014-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AKORN, INC. a50847082.htm 8-K 66264
2 EXHIBIT 10.1 a50847082ex10_1.htm EX-10.1 1142781
3 EXHIBIT 10.2 a50847082ex10_2.htm EX-10.2 1349388
4 EXHIBIT 99.1 a50847082ex99_1.htm EX-99.1 13263
5 GRAPHIC jpmorganlogo.jpg GRAPHIC 2900
6 GRAPHIC chaselogo.jpg GRAPHIC 2785
  Complete submission text file 0001157523-14-001478.txt   2581218
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 14777033
SIC: 2834 Pharmaceutical Preparations